BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 8580076)

  • 1. CD44 plays a co-stimulatory role in murine T cell activation: ligation of CD44 selectively co-stimulates IL-2 production, but not proliferation in TCR-stimulated murine Th1 cells.
    Sommer F; Huber M; Röllinghoff M; Lohoff M
    Int Immunol; 1995 Nov; 7(11):1779-86. PubMed ID: 8580076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of IL-6, IL-1, and CD28 signaling in responses of mouse CD4+ T cells to immobilized anti-TCR monoclonal antibody.
    Holsti MA; McArthur J; Allison JP; Raulet DH
    J Immunol; 1994 Feb; 152(4):1618-28. PubMed ID: 7907103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fundamental difference in the capacity to induce proliferation of naive T cells between CD28 and other co-stimulatory molecules.
    Yashiro Y; Tai XG; Toyo-oka K; Park CS; Abe R; Hamaoka T; Kobayashi M; Neben S; Fujiwara H
    Eur J Immunol; 1998 Mar; 28(3):926-35. PubMed ID: 9541588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling via CD28 costimulates lymphokine production, but does not reverse unresponsiveness to interleukin-2 in anti-CD3 triggered Th1 cells.
    Sommer F; Röllinghoff M; Lohoff M
    Eur J Immunol; 1993 Oct; 23(10):2498-502. PubMed ID: 8405051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A T cell activation antigen, Ly6C, induced on CD4+ Th1 cells mediates an inhibitory signal for secretion of IL-2 and proliferation in peripheral immune responses.
    Yamanouchi S; Kuwahara K; Sakata A; Ezaki T; Matsuoka S; Miyazaki J; Hirose S; Tamura T; Nariuchi H; Sakaguchi N
    Eur J Immunol; 1998 Feb; 28(2):696-707. PubMed ID: 9521080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD28 is not required for c-Jun N-terminal kinase activation in T cells.
    Rivas FV; O'Herrin S; Gajewski TF
    J Immunol; 2001 Sep; 167(6):3123-8. PubMed ID: 11544297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo administration of anti-murine CD3 monoclonal antibody induces selective, long-term anergy in CD8+ T cells.
    Woodle ES; Hussein S; Bluestone JA
    Transplantation; 1996 Mar; 61(5):798-803. PubMed ID: 8607186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th1 development of naive CD4+ T cells is inhibited by co-activation with anti-CD4 monoclonal antibodies.
    Goedert S; Germann T; Hoehn P; Koelsch S; Palm N; Rüde E; Schmitt E
    J Immunol; 1996 Jul; 157(2):566-73. PubMed ID: 8752903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
    Abe R; Vandenberghe P; Craighead N; Smoot DS; Lee KP; June CH
    J Immunol; 1995 Feb; 154(3):985-97. PubMed ID: 7822814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of costimulator signals and interleukin-2 on T cell receptor-mediated cell death of resting and activated CD4+ murine splenic T cells.
    Cohen DJ; Tian Y; Ooi BS; Henkart PA
    Transplantation; 1996 Feb; 61(3):486-91. PubMed ID: 8610365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD28 co-stimulatory signals induce IL-2 receptor expression on antigen-stimulated virgin T cells by an IL-2-independent mechanism.
    Toyooka K; Maruo S; Iwahori T; Yamamoto N; Tai XG; Abe R; Takahama Y; Murakami M; Uede T; Hamaoka T; Fujiwara H
    Int Immunol; 1996 Feb; 8(2):159-69. PubMed ID: 8671600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing effects of TGF-beta 2 on the Th1 cell development of naive CD4+ T cells isolated from different mouse strains.
    Hoehn P; Goedert S; Germann T; Koelsch S; Jin S; Palm N; Ruede E; Schmitt E
    J Immunol; 1995 Oct; 155(8):3788-93. PubMed ID: 7561083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of CD4(+)CD25(+)Foxp3(-) regulatory T cells by Thy-1 stimulation of CD4(+) T cells.
    Conrad DM; Coombs MR; Furlong SJ; Forward NA; Hoskin DW
    Immunol Cell Biol; 2012 Feb; 90(2):248-52. PubMed ID: 21519344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
    Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
    J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta 1 differentially regulates IL-2 expression and [3H]-thymidine incorporation in CD3 epsilon mAb- and CD28 mAb-activated splenocytes and thymocytes.
    McKarns SC; Kaminski NE
    Immunopharmacology; 2000 Jul; 48(2):101-15. PubMed ID: 10936508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell receptor-triggered activation of intraepithelial lymphocytes in vitro.
    Gramzinski RA; Adams E; Gross JA; Goodman TG; Allison JP; Lefrançois L
    Int Immunol; 1993 Feb; 5(2):145-53. PubMed ID: 8383994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion.
    Ueda Y; Levine BL; Huang ML; Freeman GJ; Nadler LM; June CH; Ward SG
    Int Immunol; 1995 Jun; 7(6):957-66. PubMed ID: 7577804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy between CD28 and CD9 costimulation for naive T-cell activation.
    Toyo-oka K; Tai XG; Yashiro Y; Ahn HJ; Abe R; Hamaoka T; Kobayashi M; Neben S; Fujiwara H
    Immunol Lett; 1997 Jun; 58(1):19-23. PubMed ID: 9436464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-27 suppresses CD28-mediated [correction of medicated] IL-2 production through suppressor of cytokine signaling 3.
    Owaki T; Asakawa M; Kamiya S; Takeda K; Fukai F; Mizuguchi J; Yoshimoto T
    J Immunol; 2006 Mar; 176(5):2773-80. PubMed ID: 16493033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.